Fig. 4
From: Novel CSF β-synuclein-specific assays signal early synaptic degeneration in Alzheimer’s disease
Comparative analysis of CSF β-syn measurements using N-terminus, mid-region, and C-terminus ELISAs in the clinical cohort. (A-C) Box plots illustrating the levels of β-syn epitopes (N-terminus, mid-region, and C-terminus) across four clinical groups: control, SCD-AD, MCI-AD, and AD-dem. (D-F) Box plots illustrating the ratio of β-syn epitopes (N-terminus, mid-region, and C-terminus) to CSF amyloid beta 42 (Aβ42) across four clinical groups: control, SCD-AD, MCI-AD, and AD-dem. β-syn: beta-synuclein, AD: Alzheimer’s disease